These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 16863850)
1. Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma. Azuhata T; Scott D; Griffith TS; Miller M; Sandler AD J Pediatr Surg; 2006 Aug; 41(8):1431-40. PubMed ID: 16863850 [TBL] [Abstract][Full Text] [Related]
2. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma. Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907 [TBL] [Abstract][Full Text] [Related]
3. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma. Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919 [TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio. Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472 [TBL] [Abstract][Full Text] [Related]
5. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Eggert A; Grotzer MA; Zuzak TJ; Wiewrodt BR; Ho R; Ikegaki N; Brodeur GM Cancer Res; 2001 Feb; 61(4):1314-9. PubMed ID: 11245427 [TBL] [Abstract][Full Text] [Related]
6. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Leverkus M; Neumann M; Mengling T; Rauch CT; Bröcker EB; Krammer PH; Walczak H Cancer Res; 2000 Feb; 60(3):553-9. PubMed ID: 10676636 [TBL] [Abstract][Full Text] [Related]
7. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837 [TBL] [Abstract][Full Text] [Related]
8. Resistance and susceptibility of human uveal melanoma cells to TRAIL-induced apoptosis. Li H; Niederkorn JY; Neelam S; Alizadeh H Arch Ophthalmol; 2005 May; 123(5):654-61. PubMed ID: 15883285 [TBL] [Abstract][Full Text] [Related]
9. Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB. Yang X; Merchant MS; Romero ME; Tsokos M; Wexler LH; Kontny U; Mackall CL; Thiele CJ Cancer Res; 2003 Mar; 63(5):1122-9. PubMed ID: 12615731 [TBL] [Abstract][Full Text] [Related]
10. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154 [TBL] [Abstract][Full Text] [Related]
11. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Hopkins-Donaldson S; Bodmer JL; Bourloud KB; Brognara CB; Tschopp J; Gross N Cancer Res; 2000 Aug; 60(16):4315-9. PubMed ID: 10969767 [TBL] [Abstract][Full Text] [Related]
12. Expression of tumor necrosis factor- alpha -related apoptosis-inducing ligand and its proapoptotic receptors is down-regulated during gastric infection with virulent cagA+/vacAs1+ Helicobacter pylori strains. Neu B; Rad R; Reindl W; Neuhofer M; Gerhard M; Schepp W; Prinz C J Infect Dis; 2005 Feb; 191(4):571-8. PubMed ID: 15655781 [TBL] [Abstract][Full Text] [Related]
13. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players. Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419 [TBL] [Abstract][Full Text] [Related]
14. [Role of caspase-8 and DR5 in TRAIL-induced apoptosis of neuroblastoma cells]. Tong HX; Zhang JH; Ma L; Lu CW; Zhang JH Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):327-30. PubMed ID: 16923369 [TBL] [Abstract][Full Text] [Related]
15. Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP. Mühlethaler-Mottet A; Bourloud KB; Auderset K; Joseph JM; Gross N Oncogene; 2004 Jul; 23(32):5415-25. PubMed ID: 15094781 [TBL] [Abstract][Full Text] [Related]
16. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Hao C; Beguinot F; Condorelli G; Trencia A; Van Meir EG; Yong VW; Parney IF; Roa WH; Petruk KC Cancer Res; 2001 Feb; 61(3):1162-70. PubMed ID: 11221847 [TBL] [Abstract][Full Text] [Related]
17. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention. Ahmad M; Shi Y Oncogene; 2000 Jul; 19(30):3363-71. PubMed ID: 10918593 [TBL] [Abstract][Full Text] [Related]
18. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis. Kim JH; Ajaz M; Lokshin A; Lee YJ Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965 [TBL] [Abstract][Full Text] [Related]
19. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. Mérino D; Lalaoui N; Morizot A; Schneider P; Solary E; Micheau O Mol Cell Biol; 2006 Oct; 26(19):7046-55. PubMed ID: 16980609 [TBL] [Abstract][Full Text] [Related]